Correlated levels of cerebrospinal fluid pathogenic proteins in drug-naïve Parkinson’s disease
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Correlated levels of cerebrospinal fluid pathogenic proteins in drug-naïve Parkinson’s disease
Authors
Keywords
Parkinson’s disease, α-Synuclein, Oligomer, Amyloid β-protein (1–42), Tau protein, Clinical symptom
Journal
BMC Neurology
Volume 19, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-06-04
DOI
10.1186/s12883-019-1346-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Japanese and North American Alzheimer's Disease Neuroimaging Initiative studies: Harmonization for international trials
- (2018) Takeshi Iwatsubo et al. Alzheimers & Dementia
- The Oligomer Hypothesis in α-Synucleinopathy
- (2017) Kenjiro Ono NEUROCHEMICAL RESEARCH
- Diagnosis and management of dementia with Lewy bodies
- (2017) Ian G. McKeith et al. NEUROLOGY
- Value of cerebrospinal fluid α-synuclein species as biomarker in Parkinson's diagnosis and prognosis
- (2016) Lucilla Parnetti et al. Biomarkers in Medicine
- Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease
- (2016) Nour K. Majbour et al. Molecular Neurodegeneration
- Oligomeropathies and pathogenesis of Alzheimer and Parkinson's diseases
- (2016) Gianluigi Forloni et al. MOVEMENT DISORDERS
- MDS clinical diagnostic criteria for Parkinson's disease
- (2015) Ronald B. Postuma et al. MOVEMENT DISORDERS
- Amyloid-β and α-synuclein cerebrospinal fluid biomarkers and cognition in early Parkinson's disease
- (2015) Ane Løvli Stav et al. PARKINSONISM & RELATED DISORDERS
- Distinct α-Synuclein Strains Differentially Promote Tau Inclusions in Neurons
- (2013) Jing L. Guo et al. CELL
- Cross-seeding effects of amyloid β-protein and α-synuclein
- (2012) Kenjiro Ono et al. JOURNAL OF NEUROCHEMISTRY
- The many faces of α-synuclein: from structure and toxicity to therapeutic target
- (2012) Hilal A. Lashuel et al. NATURE REVIEWS NEUROSCIENCE
- Total CSF α-synuclein is lower in de novo Parkinson patients than in healthy subjects
- (2012) Brit Mollenhauer et al. NEUROSCIENCE LETTERS
- Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI
- (2011) Leslie M. Shaw et al. ACTA NEUROPATHOLOGICA
- Induction of Intracellular Tau Aggregation Is Promoted by -Synuclein Seeds and Provides Novel Insights into the Hyperphosphorylation of Tau
- (2011) E. A. Waxman et al. JOURNAL OF NEUROSCIENCE
- α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study
- (2011) Brit Mollenhauer et al. LANCET NEUROLOGY
- Corticobasal degeneration: a pathologically distinct 4R tauopathy
- (2011) Naomi Kouri et al. Nature Reviews Neurology
- Detection of elevated levels of -synuclein oligomers in CSF from patients with Parkinson disease
- (2010) T. Tokuda et al. NEUROLOGY
- Mechanism of alpha-synuclein oligomerization and membrane interaction: theoretical approach to unstructured proteins studies
- (2008) Igor F. Tsigelny et al. Nanomedicine-Nanotechnology Biology and Medicine
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More